Presentations

Browse our presentations at recent scientific and industry events below and, for presentations to the ASX and investors, please  go to our investor centre.

ASGCT CAR-T Presentation May 2017
ARVO Ocular Presentation May 2017
HBV Poster EASL 2017 April, 2017
APASL Hepatitis B Presentation February, 2017
ARVO-Asia / TVS Presentation February, 2017
JPM Biotech Showcase January 9, 2017
National Roadshow (Sydney, Brisbane, Melbourne) Corporate Presentation November 2-4, 2016
HBV Poster ESGCT 2016 Oct, 2016
CAR-T Poster ESGCT 2016 Oct, 2016
AMD Poster ESGCT 2016 Oct, 2016
CAR-T Summit 2016 Poster September, 2016
ASGCT OPMD Oral Presentation May 5, 2016
ASGCT HCV Oral Presentation May 5, 2016
ASGCT HBV Oral Presentation May 5, 2016
ASGCT Abstract 145 May 5, 2016
ASGCT Abstract 143 May 5, 2016
American Association for the Study of Liver Disease Poster - TT-034 Clinical Trial Update November 13-17, 2015
American Association for the Study of Liver Disease Poster– TT-034 Toxicology Evaluation November 13-17, 2015
Chairman’s Address to the 2015 AGM of Benitec November 12, 2015
BioEquity Europe, Amsterdam - Presentation May 21-22, 2014
Pharmaceutical & Biotech Finance Leaders Forum, Brussels - CEO Presentation May 20, 2014
Investor Roadshows - Corporate Presentation March 2014
Biotech Showcase, San Francisco - Corporate Presentation January 13-15, 2014
American Association for the Study of Liver Disorders (Washington D.C.) - Oral Presentation Nov 1-5, 2013
Australia Biotech Invest (Brisbane) - Corporate Presentation October 28-29, 2013
International Symposium on Hepatitis C Virus and Related Viruses (Melbourne) - Oral Presentation Oct 7, 2013
International Symposium on Hepatitis C Virus and Related Viruses (Melbourne) - Abstract for Oral Presentation Oct 7, 2013
Canary Networks Biotech & Healthcare Investor Roadshow (Syd, Melb) - Corporate Presentation October 23-24, 2013
National Roadshow (Sydney, Melbourne, Perth) - Corporate Presentation Sep 11-19, 2013
Bioshares Biotech Summit (Queenstown, NZ) - "Lands of Opportunity" Presentation July, 2013
NIH Recombinant DNA Advisory Committee (Bethesda, MD) - Clinical Trial Protocol for TT-034 June 13, 2013